Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2010

01-06-2010 | Original Article

Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification

Authors: Chien-Hua Chen, Chiu-Kue Nien, Chi-Chieh Yang, Yung-Hsiang Yeh

Published in: Digestive Diseases and Sciences | Issue 6/2010

Login to get access

Abstract

Background

Both nonalcoholic fatty liver disease (NAFLD) and coronary artery disease (CAD) are closely related to many metabolic disorders. Multislice computed tomography (MSCT) is a reliable noninvasive method in demonstrating coronary plaque. However, the association between coronary artery calcium (CAC) score and NAFLD remains controversial.

Aims

The aim of this study is to evaluate the association between CAC score and NAFLD.

Methods

This retrospective study enrolled 295 consecutive asymptomatic subjects who had both coronary angiography by MSCT and hepatobiliary imaging during self-paid physical check-ups.

Results

NAFLD was found in 41% of the enrolled 295 subjects; gall bladder stones were found in 10.8%, and CAC > 100 with moderate-high risk of CAD was found in 12.9% of subjects. Male gender (odds ratios (OR), 3.087; 95% confidence intervals (CI), 1.092–8.729), increased age (OR, 1.108; 95% CI, 1.067–1.151), diabetes mellitus (DM) (OR, 2.968; 95% CI, 1.129–7.803), and NAFLD (OR, 2.462; 95% CI, 1.065–5.691) were the independent factors that increased the risk of CAC > 100 in binary logistic regression. The prevalence of NAFLD also increased with the severity of CAC score (≤100, 38.1%; 101–400, 58.3%; >400, 64.3%; P = 0.03).

Conclusions

Besides the traditional risk factors, such as male gender, increased age, and DM, NAFLD was also associated with moderate to high risk of CAD (CAC > 100).
Literature
1.
go back to reference Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474.CrossRefPubMed Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–2474.CrossRefPubMed
2.
go back to reference Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol. 2002;17:1136–1143.CrossRefPubMed Mulhall BP, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease: An overview. J Gastroenterol Hepatol. 2002;17:1136–1143.CrossRefPubMed
3.
go back to reference Chitturi S, Farrell GC, George J. Non-alcoholic fatty liver disease in the Asia-Pacific region: Future shock? J Gastroenterol Hepatol. 2004;19:368–374.CrossRefPubMed Chitturi S, Farrell GC, George J. Non-alcoholic fatty liver disease in the Asia-Pacific region: Future shock? J Gastroenterol Hepatol. 2004;19:368–374.CrossRefPubMed
4.
go back to reference Chen CH, Huang MH, Yang JC, et al. Prevalence of and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40:745–752.CrossRefPubMed Chen CH, Huang MH, Yang JC, et al. Prevalence of and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40:745–752.CrossRefPubMed
5.
go back to reference Kojima SI, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–961.CrossRefPubMed Kojima SI, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–961.CrossRefPubMed
6.
go back to reference Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26–31.CrossRefPubMed Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26–31.CrossRefPubMed
7.
go back to reference Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516–522.CrossRefPubMed Mathiesen UL, Franzen LE, Aselius H, et al. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis. 2002;34:516–522.CrossRefPubMed
8.
go back to reference Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.CrossRefPubMed Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745–750.CrossRefPubMed
9.
go back to reference Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann intern Med. 2005;143:722–728.PubMed Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann intern Med. 2005;143:722–728.PubMed
10.
go back to reference Marchesini G, Bugianesi E, Forlani G, et al. Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–923.CrossRefPubMed Marchesini G, Bugianesi E, Forlani G, et al. Non-alcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–923.CrossRefPubMed
11.
go back to reference Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13:1579–1584.PubMed Hamaguchi M, Kojima T, Takeda N, et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol. 2007;13:1579–1584.PubMed
12.
go back to reference Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M. Liver: an alarm for the heart? Liver International. 2007;27:891–894.CrossRefPubMed Mirbagheri SA, Rashidi A, Abdi S, Saedi D, Abouzari M. Liver: an alarm for the heart? Liver International. 2007;27:891–894.CrossRefPubMed
13.
go back to reference Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18:433–436.CrossRefPubMed Arslan U, Turkoglu S, Balcioglu S, Tavil Y, Karakan T, Cengel A. Association between nonalcoholic fatty liver disease and coronary artery disease. Coron Artery Dis. 2007;18:433–436.CrossRefPubMed
14.
go back to reference Jinzaki M, Sato K, Tanami Y, et al. Novel method of displaying coronary CT angiography: angiographic view. Circ J. 2006;70:1661–1662.CrossRefPubMed Jinzaki M, Sato K, Tanami Y, et al. Novel method of displaying coronary CT angiography: angiographic view. Circ J. 2006;70:1661–1662.CrossRefPubMed
15.
go back to reference Girshman J, Wolff SD. Techniques for quantifying coronary artery calcification. Radiol Clin N Am. 2004;42:767–771.CrossRef Girshman J, Wolff SD. Techniques for quantifying coronary artery calcification. Radiol Clin N Am. 2004;42:767–771.CrossRef
16.
go back to reference Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association writing group. Circulation. 1996;94:1175–1192.PubMed Wexler L, Brundage B, Crouse J, et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications. A statement for health professionals from the American Heart Association writing group. Circulation. 1996;94:1175–1192.PubMed
17.
go back to reference Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography detected coronary calcium reflects the angiographic extent of coronary artery atherosclerosis. Am J Cardiol. 1994;74:1272–1274.CrossRefPubMed Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M. Ultrafast computed tomography detected coronary calcium reflects the angiographic extent of coronary artery atherosclerosis. Am J Cardiol. 1994;74:1272–1274.CrossRefPubMed
18.
go back to reference Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ. 1986;292:13–15.CrossRefPubMed Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ. 1986;292:13–15.CrossRefPubMed
19.
go back to reference Leopold GR, Amberg J, Gosink BB, Mittelstaedt C. Gray scale ultrasonic cholecystography: a comparison with conventional radiological techniques. Radiology. 1976;121:445–448.PubMed Leopold GR, Amberg J, Gosink BB, Mittelstaedt C. Gray scale ultrasonic cholecystography: a comparison with conventional radiological techniques. Radiology. 1976;121:445–448.PubMed
20.
go back to reference Barakos JA, Ralls PW, Lapin SA, et al. Cholelithiasis: Evaluation with CT. Radiology. 1987;162:415–418.PubMed Barakos JA, Ralls PW, Lapin SA, et al. Cholelithiasis: Evaluation with CT. Radiology. 1987;162:415–418.PubMed
21.
go back to reference Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.CrossRefPubMed Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.CrossRefPubMed
22.
go back to reference Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll. 2004;44:923–930.CrossRef Berman DS, Wong ND, Gransar H, et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. J Am Coll. 2004;44:923–930.CrossRef
23.
go back to reference He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent ischemia. Circulation. 2000;101:244–251.PubMed He ZX, Hedrick TD, Pratt CM, et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent ischemia. Circulation. 2000;101:244–251.PubMed
24.
go back to reference Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron beam computed tomography. Circulation. 2000;101:850–855.PubMed Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron beam computed tomography. Circulation. 2000;101:850–855.PubMed
25.
go back to reference Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol. 2005;11:4838–4842.PubMed Lin YC, Lo HM, Chen JD. Sonographic fatty liver, overweight and ischemic heart disease. World J Gastroenterol. 2005;11:4838–4842.PubMed
26.
go back to reference Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. High prevalence of angina pectoris in Mexican-American men. A population with reduced risk of myocardial infarction. Ann Epidemiol. 1991;1:415–426.PubMedCrossRef Mitchell BD, Hazuda HP, Haffner SM, Patterson JK, Stern MP. High prevalence of angina pectoris in Mexican-American men. A population with reduced risk of myocardial infarction. Ann Epidemiol. 1991;1:415–426.PubMedCrossRef
27.
go back to reference Burgstahler C, Reimann A, Beck T, et al. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: Results of the new age II pilot study. Investigative Radiology. 2007;42:189–195.CrossRefPubMed Burgstahler C, Reimann A, Beck T, et al. Influence of a lipid-lowering therapy on calcified and noncalcified coronary plaques monitored by multislice detector computed tomography: Results of the new age II pilot study. Investigative Radiology. 2007;42:189–195.CrossRefPubMed
28.
go back to reference Hausleiter J, Meyer T, Hadamitzky M, Kastrati A, Martinoff S, Schomig A. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol. 2006;48:312–318.CrossRefPubMed Hausleiter J, Meyer T, Hadamitzky M, Kastrati A, Martinoff S, Schomig A. Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol. 2006;48:312–318.CrossRefPubMed
29.
go back to reference Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M. Prediction of coronary atherosclerotic disease with liver transaminase level. Liver International. 2007;27:895–900.CrossRefPubMed Adibi P, Sadeghi M, Mahsa M, Rozati G, Mohseni M. Prediction of coronary atherosclerotic disease with liver transaminase level. Liver International. 2007;27:895–900.CrossRefPubMed
30.
go back to reference Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Throm Vasc Biol. 2005;25:193–197. Kerner A, Avizohar O, Sella R, et al. Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arterioscler Throm Vasc Biol. 2005;25:193–197.
31.
go back to reference Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Diabetes. 2005;54:3140–3147.CrossRefPubMed Hanley AJ, Williams K, Festa A, Wagenknecht LE, D’Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: The Insulin Resistance Atherosclerosis Study. Diabetes. 2005;54:3140–3147.CrossRefPubMed
32.
go back to reference Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 2002;35:898–904.CrossRefPubMed Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 2002;35:898–904.CrossRefPubMed
33.
go back to reference Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and r-glutamyltransferase and mortality in the United States population. 2009; 136: 477–485. Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and r-glutamyltransferase and mortality in the United States population. 2009; 136: 477–485.
34.
go back to reference Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894–900.CrossRefPubMed Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116:894–900.CrossRefPubMed
35.
go back to reference Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med. 2005;118:816–826.CrossRefPubMed Baker JF, Krishnan E, Chen L, Schumacher HR. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Am J Med. 2005;118:816–826.CrossRefPubMed
36.
go back to reference Akabame S, Hamaguchi M, Tomiyasu KI, et al. Evaluation of vulnerable coronary plaques and nonalcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J. 2008;72:618–625.CrossRefPubMed Akabame S, Hamaguchi M, Tomiyasu KI, et al. Evaluation of vulnerable coronary plaques and nonalcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J. 2008;72:618–625.CrossRefPubMed
37.
go back to reference Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia N, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol. 2005;100:827–830.CrossRefPubMed Mendez-Sanchez N, Bahena-Aponte J, Chavez-Tapia N, et al. Strong association between gallstones and cardiovascular disease. Am J Gastroenterol. 2005;100:827–830.CrossRefPubMed
38.
go back to reference Friedman GD. The relationship between coronary heart disease and gallbladder disease: a critical review. Ann Intern Med. 1968;68:222–235. Friedman GD. The relationship between coronary heart disease and gallbladder disease: a critical review. Ann Intern Med. 1968;68:222–235.
39.
go back to reference Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: a epidemiological survey. J Gastroenterol Hepatol. 2006;21:1737–1743.CrossRefPubMed Chen CH, Huang MH, Yang JC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: a epidemiological survey. J Gastroenterol Hepatol. 2006;21:1737–1743.CrossRefPubMed
40.
go back to reference Diehl AK, Haffner SM, Hazuda HP, Stern MP. Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones? Am J Public health. 1987;77:841–845.CrossRefPubMed Diehl AK, Haffner SM, Hazuda HP, Stern MP. Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones? Am J Public health. 1987;77:841–845.CrossRefPubMed
41.
go back to reference Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation. 2001;104:2679–2684.CrossRefPubMed Newman AB, Naydeck BL, Sutton-Tyrrell K, Feldman A, Edmundowicz D, Kuller LH. Coronary artery calcification in older adults to age 99: prevalence and risk factors. Circulation. 2001;104:2679–2684.CrossRefPubMed
42.
go back to reference McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age. Results from the multi-ethnic study of atherosclerosis. Circulation. 2006;113:30–37.CrossRefPubMed McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age. Results from the multi-ethnic study of atherosclerosis. Circulation. 2006;113:30–37.CrossRefPubMed
43.
go back to reference Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678.CrossRefPubMed Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673–2678.CrossRefPubMed
44.
go back to reference Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med. 2005;22:1354–1358.CrossRefPubMed Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med. 2005;22:1354–1358.CrossRefPubMed
45.
go back to reference Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology. 2005;42:473–478.CrossRefPubMed Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in non-alcoholic fatty liver disease. Hepatology. 2005;42:473–478.CrossRefPubMed
46.
go back to reference Targher G. Association between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Hepatology. 2005;42:974–975.CrossRefPubMed Targher G. Association between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease. Hepatology. 2005;42:974–975.CrossRefPubMed
47.
go back to reference McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the diabetes heart study. Am J Gastroenterol. 2008;103:3029–3035.CrossRefPubMed McKimmie RL, Daniel KR, Carr JJ, et al. Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the diabetes heart study. Am J Gastroenterol. 2008;103:3029–3035.CrossRefPubMed
48.
go back to reference Lautamaki R, Borra R, Iozzo P, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2006;291:E282–E290.CrossRefPubMed Lautamaki R, Borra R, Iozzo P, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol Endocrinol Metab. 2006;291:E282–E290.CrossRefPubMed
Metadata
Title
Association Between Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
Authors
Chien-Hua Chen
Chiu-Kue Nien
Chi-Chieh Yang
Yung-Hsiang Yeh
Publication date
01-06-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 6/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0935-9

Other articles of this Issue 6/2010

Digestive Diseases and Sciences 6/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine